arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Quest Diagnostics Incorporated

DGX Health Care Medical Specialities
$243.28
▲ +2.6% Today
as of Oct 22, 16:48 ET
Last 30 days +2.27% Sep 14 → Oct 22
$225.43 $231.34 $237.25 $243.17 $249.08 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$226.50
High
$246.00
Low
$226.50
Volume
$2M
Avg Vol
$995,343
Mkt Cap
$25.1B
P/E (TTM)
32.46
Beta
—
52w High
$248.84
52w Low
$171.18
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 25 items

mixed ▲ 0 ● 9 ▼ 0
Oct 22 · 14:30 Investor's Business Daily
Why Quest's 'Good Enough' Third Quarter Wasn't Actually Enough
Oct 22 · 11:40 Reuters
Laboratory operator Quest reports cyber breach affecting patient records
Oct 22 · 11:09 MT Newswires
Quest Diagnostics Q3 Adjusted Earnings, Revenue Rise; Raises 2026 Guidance
▸ Show all 25 press releases & news Free account →

DGX earnings at a glance

The options market is pricing a move of about ±3.4% after the report, a range of roughly $235.03 to $251.53 from today's $243.28. Over its last 6 reports the stock rose the next day 5 times and fell 1, moving ±6.2% on average; after the most recent report on Jul 23, 2026 it moved +8.6%. That means options currently expect less movement than DGX has typically delivered. DGX beat the consensus EPS estimate in 6 of its last 6 reported quarters. Implied volatility is currently 29%. The share price of $243.28 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$171
$249
93% of range
Avg surprise (last 6)
+4.6%
Avg reaction (last 6)
+5.2%
83% positive
Latest IV / EM
29%
EM ±3.4% · $230 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.72$2.07$2.42$2.77$3.12 Actual $1.78Actual $2.05Actual $1.96Actual $1.72Actual $2.03Actual $1.99Actual $2.21Est $2.15Actual $2.62Est $2.57Actual $2.60Est $2.51Actual $2.42Est $2.35Actual $2.50Est $2.37Actual $3.12Est $2.81 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$0$799M$1.6B$2.4B$3.2B Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Jul 23, 2026Jun/2026 $3.12 $2.81 +11.0% +7.2% +8.6% earnings
Tue Apr 21, 20268K 2026-04-21 $2.50 $2.37 +5.5% — +4.4% earnings
Tue Feb 10, 20268K 2026-02-10 $2.42 $2.35 +3.0% — +7.4% earnings
Tue Oct 21, 2025Sep/2025 $2.60 $2.51 +3.6% — -3.0% earnings
Tue Jul 22, 2025Jun/2025 $2.62 $2.57 +1.9% — +7.1% earnings
Tue Apr 22, 2025Mar/2025 $2.21 $2.15 +2.8% — +6.8% earnings
Mon Sep 30, 2024Sep 2024 $1.99 — — — — financials
Sun Jun 30, 2024Jun 2024 $2.03 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.72 — — — — financials
Sat Sep 30, 2023Sep 2023 $1.96 — — — — financials
Fri Jun 30, 2023Jun 2023 $2.05 — — — — financials
Fri Mar 31, 2023Mar 2023 $1.78 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$3.04B$2.90B—$2.82B$2.76B$2.65B—$2.49B
Cost of revenue$2.02B$1.95B—$1.87B$1.82B$1.79B—$1.68B
Gross profit————————
Operating income$459M$399M—$386M$438M$346M—$330M
Net income$320M$252M—$245M$282M$220M—$226M
EPS (diluted)$2.84$2.24—$2.16$2.47$1.94—$1.99

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$626M$393M$420M$432M$319M$188M$549M$764M
Inventory$233M$225M$189M$186M$187M$189M$188M$184M
Total current assets$2.84B$2.57B$2.38B$2.41B$2.20B$2.08B$2.39B$2.62B
Total assets$16.94B$16.67B$16.23B$16.20B$15.97B$15.80B$16.15B$16.09B
Long-term debt$5.63B—$5.17B————$5.65B
Total liabilities————————
Total equity$7.52B$7.67B$7.17B$7.26B$7.26B$6.96B$6.78B$6.84B

Implied volatility — last 90 days

19%31%43%56%68% Jun 07 — IV 29% · EM ±4.1%Jun 08 — IV 29% · EM ±3.8%Jun 09 — IV 32% · EM ±4.1%Jun 10 — IV 29% · EM ±3.4%Jun 11 — IV 27% · EM ±3.0%Jun 12 — IV 28% · EM ±2.8%Jun 15 — IV 31% · EM ±2.2%Jun 16 — IV 33% · EM ±2.0%Jun 17 — IV 42% · EM ±1.7%Jun 19 — IV 23% · EM ±5.2%Jun 22 — IV 24% · EM ±4.9%Jun 23 — IV 23% · EM ±4.7%Jun 24 — IV 25% · EM ±5.0%Jun 25 — IV 27% · EM ±5.3%Jun 26 — IV 23% · EM ±4.5%Jun 29 — IV 23% · EM ±4.0%Jun 30 — IV 24% · EM ±4.1%Jul 01 — IV 23% · EM ±3.9%Jul 02 — IV 27% · EM ±4.4%Jul 03 — IV 25% · EM ±3.9%Jul 06 — IV 26% · EM ±3.6%Jul 07 — IV 23% · EM ±3.1%Jul 08 — IV 26% · EM ±3.2%Jul 09 — IV 25% · EM ±3.0%Jul 10 — IV 21% · EM ±2.3%Jul 13 — IV 45% · EM ±3.7%Jul 14 — IV 39% · EM ±2.8%Jul 15 — IV 46% · EM ±2.7%Jul 16 — IV 44% · EM ±1.8%Jul 20 — IV 31% · EM ±7.3%Jul 21 — IV 30% · EM ±7.0%Jul 22 — IV 40% · EM ±9.2%Jul 23 — IV 27% · EM ±6.0%Jul 24 — IV 26% · EM ±5.8%Jul 27 — IV 22% · EM ±4.7%Jul 28 — IV 26% · EM ±5.3%Jul 29 — IV 28% · EM ±5.6%Jul 30 — IV 27% · EM ±5.3%Jul 31 — IV 26% · EM ±5.1%Aug 03 — IV 26% · EM ±4.6%Aug 04 — IV 28% · EM ±4.8%Aug 05 — IV 27% · EM ±4.6%Aug 06 — IV 24% · EM ±3.9%Aug 07 — IV 25% · EM ±4.0%Aug 10 — IV 24% · EM ±3.3%Aug 11 — IV 24% · EM ±3.2%Aug 12 — IV 25% · EM ±3.1%Aug 13 — IV 25% · EM ±3.0%Aug 14 — IV 30% · EM ±3.3%Aug 17 — IV 33% · EM ±2.7%Aug 18 — IV 37% · EM ±2.7%Aug 19 — IV 34% · EM ±2.0%Aug 20 — IV 35% · EM ±1.4%Aug 24 — IV 22% · EM ±4.7%Aug 25 — IV 23% · EM ±4.6%Aug 26 — IV 23% · EM ±4.5%Aug 27 — IV 20% · EM ±4.0%Aug 28 — IV 21% · EM ±4.0%Aug 31 — IV 19% · EM ±3.4%Sep 01 — IV 21% · EM ±3.7%Sep 02 — IV 21% · EM ±3.5%Sep 03 — IV 21% · EM ±3.4%Sep 04 — IV 24% · EM ±3.8%Sep 07 — IV 27% · EM ±3.8%Sep 08 — IV 30% · EM ±3.9%Sep 09 — IV 31% · EM ±3.9%Sep 10 — IV 31% · EM ±3.6%Sep 11 — IV 38% · EM ±4.2%Sep 14 — IV 41% · EM ±3.4%Sep 15 — IV 33% · EM ±2.4%Sep 16 — IV 39% · EM ±2.3%Sep 17 — IV 69% · EM ±2.9%Sep 21 — IV 28% · EM ±5.8%Sep 22 — IV 24% · EM ±5.0%Sep 23 — IV 25% · EM ±5.0%Sep 24 — IV 24% · EM ±4.7%Sep 25 — IV 24% · EM ±4.7%Sep 28 — IV 24% · EM ±4.2%Sep 29 — IV 25% · EM ±4.4%Sep 30 — IV 27% · EM ±4.5%Oct 01 — IV 27% · EM ±4.4%Oct 02 — IV 25% · EM ±3.9%Oct 05 — IV 35% · EM ±4.9%Oct 06 — IV 27% · EM ±3.6%Oct 07 — IV 27% · EM ±3.4%Oct 08 — IV 29% · EM ±3.4%

Sector peers

LH
Labcorp Holdings Inc.
$25.3B $329.93+2.1%
GH
Guardant Health, Inc.
$22.6B $162.94+0.2%
CNC
Centene Corporation
$32.1B $71.24+0.6%
MOH
Molina Healthcare Inc
$10.2B $216.64-1.4%
OSCR
Oscar Health, Inc.
$10.2B $33.32-1.0%
ILMN
Illumina, Inc.
$40.4B $269.40+0.6%

DGX earnings FAQ

What is DGX's expected move for earnings?

Options currently price a move of about ±3.4%, or $8.25 per share either way from $243.28.

How does DGX stock usually react to earnings?

Across the last 6 reports the average next-day move was ±6.2%, up 5 times and down 1 times.

What is DGX's implied volatility?

DGX's at-the-money implied volatility is about 29% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in